11 August 2025
Cirata plc
("Cirata" or the "Company")
Completion of DevOps Divestment
Cirata plc (LSE: CRTA) today announces the successful completion of the divestment of its DevOps assets (the "Transaction"), further to the Company's announcement of 15 July 2025.
Cirata received $2.5m upon successful closing of the Transaction with BlueOptima Ltd ("BlueOptima") (a UK-based leading provider of software engineering insights). Final consideration of up to $1.0m will be payable in December 2025, conditional upon the transfer of Cirata's DevOps customers to BlueOptima. Further updates will be provided as appropriate.
This divestment reconfirms Cirata's focus on leveraging the growth potential of its Data Integration ("DI") business, the Company's core growth driver.
For further information, please contact:
| Cirata | +1 (925) 380 1728 |
| Stephen Kelly, Chief Executive Officer | |
| Ricardo Moura, Chief Financial Officer | |
| Daniel Hayes, Investor Relations | |
| | |
| FTI Consulting | +44 (0)20 3727 1137 |
| Matt Dixon / Kwaku Aning / Usama Ali | |
| | |
| Stifel (Nomad and Joint Broker) | +44 (0)20 7710 7600 |
| Fred Walsh / Brough Ransom / Ben Good | |
| | |
| Panmure Liberum (Joint Broker) | +44 (0)20 3100 2000 |
| Max Jones / John More | |
About Cirata
Cirata, accelerates data-driven revenue growth by automating data transfer and integration to modern cloud analytics and AI platforms without downtime or disruption. With Cirata, data leaders can leverage the power of AI and analytics across their entire enterprise data estate to freely choose analytics technologies, avoid vendor, platform, or cloud lock-in while making AI and analytics faster, cheaper, and more flexible. Cirata's portfolio of products and technology solutions make strategic adoption of modern data analytics efficient and automated.
For more information about Cirata, visit www.cirata.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.